首页> 美国卫生研究院文献>The Open AIDS Journal >A Typology of Intellectual Property Management for Public Health Innovation and Access: Design Considerations for Policymakers
【2h】

A Typology of Intellectual Property Management for Public Health Innovation and Access: Design Considerations for Policymakers

机译:公共卫生创新和获取的知识产权管理类型学:决策者的设计考虑因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This paper seeks to set the practical discipline of public interest intellectual property (IP) management in public health into its broader policy context. The most immediate and direct impact of IP systems on public welfare results not from international standards nor from national legislation – though these norms are fundamentally important - but rather from the accumulated impact of numerous practical choices whether or not to seek IP protection; where and where not; and how any exclusive rights are deployed, by whom, and to what end. IP management is the essentially practical exercise of limited exclusive rights over protected subject matter, the judicious use of those rights to leverage outcomes that advance an institution's or a firm's objectives. Exclusive rights are used to construct and define knowledge-based relationships, to leverage access to technology and other necessary resources, and to enhance market-based incentives. IP management choices range across a broad spectrum, spanning public domain strategies, open or exclusive licensing, and strong exclusivity. The idea of ‘exclusive rights’, as a specific legal mechanism, can run counter to expectations of greater openness and accessibility, but actual outcomes will depend very much on how these mechanisms are used in practice. For public interest or public sector institutions concerned with health research and development, particularly the development of new medicines, IP management choices can be just as critical as they are for private firms, although a predominant institutional concentration on advancing direct public interest objectives may lead to significantly different approaches in weighing and exercising practical choices for IP management: even so, a private sector approach should not be conflated with exclusivity as an end in itself, nor need public interest IP management eschew all leverage over IP. This paper offers a tentative framework for a richer typology of those choices, to give a sense of practical options available and the factors that might guide their application, but without advocating any particular approach.
机译:本文旨在将公共卫生领域的公共利益知识产权(IP)管理的实践学科纳入其更广泛的政策环境。知识产权制度对公共福利的最直接和直接的影响,不是源于国际标准也不是国家立法,尽管这些准则至关重要,而是源于无论是否寻求知识产权保护的众多实际选择的累积影响;哪里不哪里以及如何部署任何排他性权利,由谁进行部署以及目的何在。知识产权管理实际上是对受保护客体的有限专有权的一种实际实践,是对这些权利的明智使用,以利用促进机构或公司目标的成果。专有权用于构建和定义基于知识的关系,以利用对技术和其他必要资源的访问,并增强基于市场的激励机制。 IP管理选择范围广泛,涵盖公共领域策略,开放或独家许可以及强大的排他性。作为一种特定的法律机制,“专有权”的概念可能与人们对更大程度的开放性和可及性的期望背道而驰,但是实际结果将在很大程度上取决于这些机制在实践中的使用方式。对于关注健康研究与开发(尤其是新药开发)的公共利益或公共部门机构,知识产权管理的选择与私人公司一样重要,尽管主要集中于推进直接公共利益目标的机构可能导致在权衡和行使IP管理的实际选择时,方法大不相同:即使如此,私有部门的方法本身也不应与专有性混为一谈,也不需要公共利益IP管理避免使用IP的所有杠杆作用。本文为这些选择的更丰富的类型学提供了一个初步的框架,以给出可用的实际选择以及可能指导其应用的因素,但不主张采用任何特定方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号